Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment? [electronic resource]
Producer: 20160111Description: 469-73 p. digitalISSN:- 2038-2529
- Adult
- Aged
- Aged, 80 and over
- Anastrozole
- Androstadienes -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Aromatase Inhibitors -- administration & dosage
- Arthralgia -- chemically induced
- Breast Neoplasms -- chemistry
- Chemotherapy, Adjuvant
- Female
- Follow-Up Studies
- Humans
- Letrozole
- Logistic Models
- Medication Adherence
- Middle Aged
- Neoplasm Grading
- Neoplasm Staging
- Nitriles -- administration & dosage
- Odds Ratio
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- Risk Factors
- Triazoles -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.